Topic prioritisation
Showing 21 to 24 of 24
| Title | Prioritisation programme | Decision | Decision date |
|---|---|---|---|
| Dupilumab for children with severe atopic dermatitis [TSID10434] | None selected | Not selected | |
| Dupilumab for maintenance treatment of uncontrolled moderate to severe asthma in children 6 to 11 years [TSID10085] | None selected | Not selected | |
| Moor LDLS-BI for assessing burn depth and healing potential in children and adults | None selected | Not selected | |
| Fingolimod for treating relapsing multiple sclerosis in children and young people [ID1378] | None selected | Not selected |